We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

MedAvail Holdings Inc (MDVL) USD0.001

Sell:$1.50 Buy:$1.61 Change: $0.08 (4.91%)
Market closed |  Prices as at close on 25 May 2022 | Switch to live prices |
Change: $0.08 (4.91%)
Market closed |  Prices as at close on 25 May 2022 | Switch to live prices |
Change: $0.08 (4.91%)
Market closed |  Prices as at close on 25 May 2022 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

MedAvail Holdings, Inc. (MedAvail) is a telehealth-enabled pharmacy technology company. The Company has developed and commercialized a pharmacy, mobile application, kiosk and drive-thru solution. MedAvail's principal technology and product is the MedCenter, a pharmacist controlled, customer-interactive, prescription dispensing system, which is similar to a pharmacy in a box or prescription-dispensing automated teller machine (ATM). The MedCenter facilitates live pharmacist counselling through two-way audio-video communication with the ability to dispense prescription medicines under pharmacist control. MedAvail also operates SpotRx (the Pharmacy) a full-service retail pharmacy utilizing the Company’s automated pharmacy technology. The Company's segments include Retail Pharmacy Services Segment and Pharmacy Technology Segment.

Contact details

4720 E Cotton Gin Loop, Suite 220
United States
+1 (905) 8120023

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
$119.95 million
Shares in issue:
70.56 million
Drug Retail
United States
US dollar

Key personnel

  • Robert Faulkner
    Chairman of the Board
  • Mark Doerr
    Chief Executive Officer, Director
  • Brian Schlerf
    Interim Chief Financial Officer, Controller
  • Ramona Seabaugh
    Chief Financial Officer
  • Joan O'Rourke
    President of SpotRx
  • Will Misloski
    Chief Marketing Officer
  • Neil Prezioso
    Chief Pharmacy Officer
  • Dave Rawlins
    Chief Commercial Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.